Join the club for FREE to access the whole archive and other member benefits.

Natalie Yivgi-Ohana

Co-Founder and the Chief Executive Officer at Minovia Therapeutics

Natalie Yivgi Ohana, PhD, is a life science entrepreneur, Scientific founder and CEO of Minovia Therapeutics Ltd. Led the company since incorporation in 2011; Holds a Ph.D. in Biochemistry from the Hebrew University; Postdoctoral fellowship at the Weizmann Institute; Twenty+ years experience in mitochondrial research that led to the development of a novel mitochondrial cell therapy approach to treat mitochondrial diseases: from ideation to clinical stage; from a small start up to a global organization with a team of Biotech leaders. Raised $27M from private investors; established collaborations with top researchers and clinical centers around the world, as well as strategic partnership with a leading pharma company.

Visit website:


See also: Company Minovia Therapeutics - Clinical-stage international biotechnology research company focused on treatment innovation for mitochondrial disease

Natalie Yivgi-Ohana is also referenced in the following:

Longevity Nation

26-Mar-2023 to 27-Mar-2023

Conference Enhancing Research, Development and Education for Healthy Longevity organized by Vetek Association